Immuron Limited, a biopharmaceutical company, researches, develops, and commercializes polyclonal antibodies in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products.
Immuron stock last closed at $1.98, up 3.13% from the previous day, and has decreased 9.01% in one year. It has overperformed other stocks in the Biotechnology industry by 0.24 percentage points. Immuron stock is currently +42.45% from its 52-week low of $1.39, and -38.32% from its 52-week high of $3.21.
There are currently 227.8M shares of IMRN outstanding. The market capitalization of IMRN is $11.28M. In the last 24 hours, 512 IMRN shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy IMRN shares.
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your stock purchase by opening an account with eToro today.
Open eToro AccountNow that you've chosen the best brokerage, you need to fill out some personal info so you are able to invest in IMRN stock today.
Now that you've finished signing up on the best stock app, your next step is to transfer the money for your investment:
Check out the tutorial below for more details transferring funds into your new brokerage account.
Once you have identified the best place to buy Immuron stock, it's crucial to evaluate their stock prior to investing, so you can wrap your head around the risk as well as the opportunity.
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on IMRN's stock page.
You can use many financial metrics, analyses, models, and charts to gauge IMRN's fair value.
Using relative valuations measures:
You can do more valuation research on IMRN's stock here.
Last year, IMRN revenue was $1.16M. Over the last 5 year, IMRN's revenue has gone up by -1.83% per year. This was slower than the Biotechnology industry average of 108.28%.
You can research IMRN's earnings and revenue performance here.
In the past year, insiders at IMRN have not bought or sold any shares.
Research more about who owns IMRN stock here.
No, Immuron doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
There are two primary order types:
Press the Open button and your broker will place your order.
If you want additional help investing in stocks on eToro, watch the how to video below:
Now that you own some shares in IMRN, you'll want to stay up-to-date on your investment.
Create a watchlist to track the most important metrics related to your IMRN stock.
To summarize, here are the 6 steps to buy Immuron stock:
If you are looking for a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to track your new investment in Immuron, hit the button below to create your watchlist.